In order to confirm that the induction of autophagy by crizotinib in lung cancer cells was the result of MET inhibition, we used small-interference RNA to specifically target MET, and revealed that knockdown of MET mRNA resulted in the downregulation of MET expression. The gene discussed is MET; the disease is lung carcinoma.